EHRA EUROPACE 2013 - European Society of Cardiology

tUEsdAy 25 JUnE 2013 - AFTERNOON
14:00 - 15:30 Oral Abstract session ithaca
Oral Abstract Session: optimizing right ventricular and left ventricular pacing
Chairpersons: M. brignole (lavagna, it); to be announced
14:00 Achieving very low percentage of ventricular pacing with safe-R pacing mode does
not prevent atrial fibrillation and remodelling of the left heart chambers compared
to ddd pacing with long AV delay 855
B. Thibault, A. Ducharme, C. Simpson, J.F. Sarrazin, C. Stuglin, M. Barrero-Garcia,
I. Greiss, R. Williams, M. Senaratne, S. Mcnicoll (Montreal, Kingston, Québec city,
Saskatoon, Trois-Rivières, Montréal, Edmonton and Saint Jérôme, CA)
14:15 Reduced pacemaker patient mortality associated with remote monitoring 856
R.K. Thakur, B. Faulknier, J.D. Snell, N. Dalal, M. Richards (Lansing, MI, Charleston WV,
Sylmar, Ca and Toledo, OH, US)
14:30 deterioration of left ventricular (lV) systolic function in patients (Pts) treated
with antibradycardic pacemakers (PM) and rightventricular (RV) stimulation: is the
stimulation site of importance? 857
M. Ebert, J. Stockinger, K. Astheimer, T. Blum, C. Restle, T. Arentz, D. Kalusche
(Freiburg - Bad Krozingen, DE)
14:45 device infection risk factors for pacemaker implantation: a nationwide
population-based study 858
S.P. Hung, P.R. Chen, T.S. Chen (Tao-Yuan and Taoyuan, TW)
15:00 Feasibility, efficacy and safety of percutaneous retrieval of a leadless cardiac
pacemaker in an in vivo ovine model. 859
J. Sperzel, A. Khairkhahan, D. Ligon, S. Zaltsberg (Bad Nauheim, DE; Sunnyvale, US)
15:15 long term clinical outcome of cardiac resynchronisation therapy according to
baseline QRs duration: a multi-national, ten-year experience. 860
M. Gasparini, C. Leclercq, C.-M. Yu, A. Auricchio, J. Steinberg, B. Lamp, A. Curnis,
C. Klersy, F. Leyva (Rozzano, Brescia and Pavia, IT; Rennes, FR; Hong Kong, HK;
Lugano, CH; New York, US; Bad Oeynhausen, DE; Birmingham, GB)
14:00 - 15:30 symposium Mykonos
ICD: controversial indications in primary prevention
Chairpersons: J. Kautzner (Prague, CZ); J.M. Almendral Garrote (Madrid, Es)
Clinical Practice
14:00 Repolarisation variability: a useful index in ICD decision making? 861
M.A. Vos (Utrecht, NL)
14:22 When to implement an ICD after AMI? 862
Y.G. Yap (Kuala Lumpur, MY)
14:45 Is there an indication for primary prevention in patients with chronic kidney disease? 863
P. Korantzopoulos (Ioannina, GR)
15:07 the role of dual chamber devices in primary prevention. 864
F. Arribas (Madrid, ES)
127
tuesday
sessions